United States — Food and Drug Administration & China
13 shared events · Importance 7 · Last updated May 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with Dr. Marty Makary's resignation and Kyle Diamantas taking over as acting commissioner.
China: China is considered the second strongest nation militarily and is a key player in trade discussions with the United States. It is also helping Kuwait build a port.
May 13, 2026 · 6 articles
International
United States — Food and Drug Administration: Marty Makary is resigning as head of the United States — Food and Drug Administration after facing complaints from various groups and internal staff.
China: China is helping Kuwait build a port on Kuwait — Bubiyan Island and is a major buyer of Iranian oil, making it a key player in regional stability and the Iran war discussions.
May 12, 2026 · 9 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration provided clarity on the reclassification pathway for OAY-related equipment, which is expected to create a larger commercial opportunity for Photocure in the U.S. market.
China: China approved the System blue BLC platform and Cevira, leading to milestone payments for Photocure.
May 07, 2026 · 6 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration experienced leadership shake-ups, with its top drug official, Dr. Tracy Beth Høeg, being fired and Commissioner Marty Makary resigning.
China: China hosted state visits from both Donald Trump and Vladimir Putin, deepening its relations with Russia and potentially reopening a key market for Boeing.
May 16, 2026 · 7 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is experiencing leadership changes with the resignation of Marty Makary, leading to uncertainty about the fate of various initiatives.
China: China is being sought by the United States to influence Iran to end the war and reopen the Strait of Hormuz. President Xi Jinping is meeting with Donald Trump to discuss trade and the Iran conflict.
May 12, 2026 · 49 articles
International
United States — Food and Drug Administration: The United States — Food and Drug Administration is conducting a new review of mifepristone's safety, and a court panel is requiring in-person distribution of the pill.
China: China's U.N. ambassador Fu Cong emphasized the importance of a steady relationship with the United States ahead of a Trump-Xi summit.
May 01, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Priority Review to BeOne Medicines' Next-Generation BCL-2 Inhibitor and sets manufacturing standards for BeOne Medicines' Suzhou facility.
China: China hosts two of BeOne Medicines' production sites in Suzhou and Guangzhou, supporting manufacturing and R&D.
May 11, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Priority Review to Eisai's supplemental Biologics License Application for a subcutaneous starting dose with Lecanemab Iqlik, with a PDUFA date set for August 24, 2026.
China: China is one of the countries where Lecanemab is approved for intravenous maintenance dosing and where the Biologics License Application for subcutaneous formulation was accepted and designated for priority review.
May 15, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and China interact across events, view sentiment trends, and discover connected entities.
Open Dashboard